How can the same people argue that we cannot impose fair, objective caps or rules on amounts charged by hospitals, but can impose fair, objective caps or rules on amounts charged by drug companies? (Photo: Shutterstock)
As 2019 came to an end, and we entered the politically charged year of 2020, one topic dominated the debate stages and legislator's minds: health care. Specifically, two issues relating to health care seemed to be primary amongst candidate's and law maker's talking points; that being the cost of drugs and surprise balance billing.
Surprise balance billing is particularly troublesome because whether it's an emergency or out-of-network provider operating at an in-network facility, the patient either didn't know the provider was out-of-network, or had no choice in the matter. Politicians see this issue, and their mouths water. It victimizes innocent people, in dire need of care, when they are most exposed. It also represents a chance for bi-partisan "wins" in the hotly debated area of health care.
Recommended For You
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
